Study of vortioxetine for teens with depression in Japan
Treatments studied
Part of Mental health clinical trials.
This trial tests whether vortioxetine helps reduce symptoms of major depression in Japanese teenagers aged 12-17. It compares the study drug to a placebo to see if it is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old and live in Japan.
- You have been diagnosed with major depressive disorder or persistent depressive disorder with a current major depressive episode.
- Your depression symptoms are at least moderate in severity.
- You have not tried vortioxetine before.
- You are not currently taking other antidepressants that would interfere.
- You and your parent or guardian can attend all study visits and agree to video recordings for assessment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called bupropion (an antidepressant) in children and teens with depression. It aims to see if it is safe and effective for this age group.
This trial uses computer modeling based on brain measurements to try to predict which depression treatment will work for you. It may help match you with the most effective option faster by understanding your motivation-related brain patterns.
This study tests a new antidepressant called Toludevenlafaxine for people with recurring depression. It aims to see if the medicine is safe and works well over a long period.
This study tests a new oral medication called Zelquistinel (taken as a tablet) against a placebo for treating major depressive disorder. Researchers want to see if it can reduce depression symptoms, especially when other antidepressants haven't been tried or haven't worked.
This study tests a new antidepressant tablet against an approved one to see which works better and is safer for adults with major depression. It may help find a more effective option for treating depressive symptoms.
This trial tests a step-by-step approach to treating moderate-to-severe depression in teens. It may help find a treatment path that improves mood while keeping care safe, including for some teens who have suicidal thoughts but do not need inpatient care.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.